Fresenius Medical Care accelerates income growth to 23% in the second quarter of 2026 while advancing its strategic agenda

Organic revenue growth1 of 5% with growth in all operating segments Operating income2 grew by 23%, resulting in further margin expansion to 11.7% Reported operating income grew by 10% and reported net income3 decreased by 3% Earnings per share2 (EPS) increased by 28%, supported by the...